Informations sur le produit
- Bml 210
- Cay 10433
- N<sup>1</sup>-(2-Aminophenyl)-N<sup>8</sup>-phenyloctanediamide
- Octanediamide, N-(2-aminophenyl)-N′-phenyl-
- Octanediamide, N<sup>1</sup>-(2-aminophenyl)-N<sup>8</sup>-phenyl-
- octanediamide, N1
BML-210 is a protein synthesis inhibitor that has been shown to have the ability to inhibit the proliferation of cancer cells. It inhibits cell cycle progression by modulating the activity of cyclin-dependent kinases. BML-210 also inhibits the production of nitric oxide, which is a key mediator in autoimmune diseases and other inflammatory disorders. BML-210 has been shown to be effective for treating cervical cancer, as well as cardiac and mouse hippocampal cancers. The drug also has an effect on DNA methyltransferase, which is an enzyme that controls gene expression and can inhibit tumor growth. In addition, BML-210 can be used to treat all types of cancer that are resistant to treatment with taxane drugs.
Propriétés chimiques
Question d’ordre technique sur : 3D-MWA03417 BML-210
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
